A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)
NCT02231697 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 161
Last updated 2022-07-29
Summary
This retrospective medical chart review (RECENSUS) of approximately 100 XLMTM patients (with a goal to obtain 50 deceased and 20 living records) will provide further knowledge about the clinical manifestations and recorded medical management of XLMTM and potentially inform the design of future therapeutic intervention studies.
Conditions
- Males With X-linked Myotubular Myopathy (XLMTM)
Interventions
- OTHER
-
Non-interventional, retrospective medical chart review
Non-interventional, retrospective medical chart review
Sponsors & Collaborators
-
Astellas Gene Therapies
lead INDUSTRY
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
- United Kingdom
Study Locations
More Related Trials
-
Nemaline Myopathy Clinical Research Network (NM-CTRN)
NCT06774703 ·Status: NOT_YET_RECRUITING
-
Safety Study of XT-150 in Participants With ALS
NCT06704347 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
NCT03179631 ·Status: COMPLETED ·Phase: PHASE3
-
Phenotypes, Biomarkers and Pathophysiology in Spastic Ataxias
NCT04297891 ·Status: UNKNOWN
-
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
NCT03124459 ·Status: TERMINATED ·Phase: PHASE2
-
Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators
NCT07052929 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies
NCT03351270 ·Status: COMPLETED ·Phase: NA
-
Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders
NCT05474235 ·Status: RECRUITING
-
Multiple Doses of AT-1501-A201 in Adults With ALS
NCT04322149 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT06441682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Natural History Study of Mitochondrial Myopathy
NCT05250375 ·Status: RECRUITING
-
A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS
NCT05053035 ·Status: TERMINATED ·Phase: PHASE2
-
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
NCT02327845 ·Status: ENROLLING_BY_INVITATION
-
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT03160898 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
NCT04042025 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phenotype, Genotype and Biomarkers 2
NCT04875416 ·Status: ACTIVE_NOT_RECRUITING
-
Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
NCT01826487 ·Status: COMPLETED ·Phase: PHASE3
-
Amyotrophic Lateral Sclerosis Registry in Thailand
NCT07175935 ·Status: RECRUITING
-
A Natural History Study of Patients With GNE Myopathy and GNE-Related Diseases
NCT01417533 ·Status: COMPLETED
-
Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia
NCT03357978 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA)
NCT04851873 ·Status: COMPLETED ·Phase: PHASE3
-
Genomic Translation for Amyotrophic Lateral Sclerosis Care
NCT02795897 ·Status: COMPLETED
-
Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
NCT00592553 ·Status: COMPLETED ·Phase: PHASE2
-
Study of ALS Reversals 2: Genetic Analyses
NCT03464903 ·Status: COMPLETED
-
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
NCT01849770 ·Status: COMPLETED ·Phase: PHASE2